To evaluate whether the risk of bone fragility on computed tomography (CT) (scanographic bone attenuation coefficient of the first lumbar vertebra (SBAC-L1)) is associated with the severity of spine structural involvement (mSASSS) in patients with ankylosing spondylitis (AS). This retrospective study included AS patients, followed from 2009 to 2017, who fulfilled the New York criteria and who underwent thoraco-abdomino-pelvic CT and radiography (spine, pelvis). The structural involvement was retained for mSASSS ≥ 2. The SBAC-L1 was measured in Hounsfield units (HU). A SBAC-L1 ≤ 145 HU was used to define patients at risk of vertebral fracture (VF). A total of 73 AS patients were included (mean age: 60.3 (± 10.7) years, 8 women (11%), mean disease duration: 24.6 years (± 13.9)). Sixty patients (82.2%) had a mSASSS ≥ 2 (mean score 20.7 (± 21.2)). The mean SBAC-L1 was 141.1 HU (± 45), 138.1 HU (± 44.8) and 154.8 HU (± 44.9) in the total, mSASSS ≥ 2 and mSASSS < 2 populations, respectively. Patients with bone bridges had lower SBAC-L1 than mSASSS ≥ 2 patients without ankylosis (p = 0.02) and more often SBAC-L1 ≤ 145 HU (73% vs 41.9%, p = 0.006). A SBAC-L1 ≤ 145 HU was not associated with structural spine involvement, but patients with bone bridges had significantly decreased SBAC-L1 and an increased probability of being under the fracture threshold.
Objective: This study aimed to investigate the relationship between spinal axial spondyloarthritis (axSpA)-related lesions and degenerative lesions (DLs) over 10 years (10Y). Methods: Whole spine MRI and cervical/lumbar spine radiographs at baseline/5Y/10Y from patients with axSpA from the DESIR cohort were assessed for axSpA-related lesions and DLs by three independent readers, different teams for the two lesion types. We used multilevel (patient and vertebra, considering consensus across readers), standard and time-lagged autoregressive generalized estimating equation (GEE) models. The relationship between syndesmophytes and the subsequent development of osteophytes/syndesmophytes in adjacent vertebrae on radiographs was analysed using a time-lagged autoregressive GEE model, after excluding vertebrae with both lesions. All models were adjusted for age, sex, HLA-B27 status, BMI, smoking and job type, and bDMARDs during follow-up. Results: Data from 326 patients (35 [S.D. = 9] years; 46% men) showed a significant association between axSpA-related lesions on MRI and the total number of DLs on MRI, though the effect sizes were small (β-coefficients: 0.07–0.17). On radiographs, paravertebral syndesmophytes were significantly associated with the total number of DLs (β-coefficient: 0.37; 95%CI: 0.26–0.48). However, these associations were not found in time-lagged autoregressive models. Syndesmophytes increased the risk of adjacent syndesmophyte [odds ratio (OR):6.92; 95%CI: 2.44–19.61], but not of osteophytes (OR: 1.05; 95%CI: 0.25–4.36). Conclusion: Although significant associations were found between axSpA-related lesions and DLs at the same time point, no temporal relationship was observed. On radiographs, syndesmophytes increased the risk of syndesmophytes at adjacent levels, but there was no association with osteophyte development. AxSpA-related lesions and DLs coexist, but progress independently of each other.
Background/objectives: Both erosions and osteoporosis in rheumatoid arthritis (RA) have common mechanisms. The aim of this study was to evaluate the relationship between erosion and bone mineral density (BMD) in RA and whether it can be driven by autoimmunity. Methods: Patients fulfilling the ACR 1987- or ACR/EULAR 2010-criteriae for RA. performed radiographs (erosions evaluated by the modified Sharp/van der Heidje erosion score) and biology for anti-citrullinated peptide antibodies (ACPAs), rheumatoid factors (RFs) and anti-nuclear antibodies (ANAs) at intervals of less than 2 years from dual-energy X-ray absorptiometry (DXA) for BMD assessment. Results: A total of 149 patients were included, (75.8% women, mean age of 62 y.o (SD 9.61) and a median disease duration of 132 months [60; 240]). A total of 61.1% patients were ACPA positive, 79.9% were erosive and 10.7% had a hip or spine T-score ≤ −2.5. A higher erosion score was associated with a lower BMD (value: −0.222; p = 0.009) and T-score (value −0.397; p < 0.0001) in the hip. ACPA status was associated with a higher erosion score (63.0 (53.2) vs. 45.5 (44.1) for ACPA- (p = 0.04)). ACPA titers were associated with a lower BMD in the hip (value −0.216; p = 0.01). In linear regression, erosion and BMD were still associated, but this association is not driven by ACPA status or titer. Conclusions: In RA patients, erosions and BMD are inversely associated but this relationship does not seem to be driven by autoimmunity only. However, the presence of ACPA or erosion should lead to osteoporosis screening.
Ten-year longitudinal imaging analyses demonstrated the sequential development of spinal degenerative lesions at MRI and radiography at the same and adjacent vertebral levels, clarifying their temporal relationships and progression.